NNGRF Stock - NanoRepro AG
Unlock GoAI Insights for NNGRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.65M | $3.25M | $38.49M | $162.72M | $16.93M |
| Gross Profit | $2.95M | $1.89M | $9.90M | $53.75M | $4.66M |
| Gross Margin | 63.4% | 58.3% | 25.7% | 33.0% | 27.5% |
| Operating Income | $-3,623,835 | $-5,340,589 | $-4,533,810 | $38.81M | $2.80M |
| Net Income | $-2,045,757.4 | $-4,685,300.95 | $-3,724,237 | $29.72M | $1.69M |
| Net Margin | -44.0% | -144.3% | -9.7% | 18.3% | 10.0% |
| EPS | $-0.16 | $-0.37 | $-0.29 | $2.30 | $0.18 |
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.
Visit WebsiteEarnings History & Surprises
NNGRFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 29, 2024 | — | $-0.10 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.18 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.22 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.33 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.33 | — | — |
Q2 2021 | Jun 30, 2021 | — | $2.38 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.18 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.04 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.12 | — | — |
Q2 2018 | Apr 11, 2018 | — | — | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.06 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.07 | — | — |
Q2 2017 | Apr 21, 2017 | — | — | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.01 | — | — |
Q3 2016 | Sep 30, 2016 | — | — | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.11 | — | — |
Q2 2016 | Apr 20, 2016 | — | — | — | — |
Q3 2015 | Sep 30, 2015 | — | — | — | — |
Latest News
Frequently Asked Questions about NNGRF
What is NNGRF's current stock price?
What is the analyst price target for NNGRF?
What sector is NanoRepro AG in?
What is NNGRF's market cap?
Does NNGRF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to NNGRF for comparison